The Impact of Depression Symptoms in Patients with Parkinson’s Disease: A Novel Case-Control Investigation

Ana María Jiménez-Cebrián, Ricardo Becerro- de-Bengoa-Vallejo, Marta Elena Losa-Iglesias, Daniel López-López, César Calvo-Lobo, Patricia Palomo-López, Carlos Romero-Morales and Emmanuel Navarro-Flores
Additional contact information
Ana María Jiménez-Cebrián: Department Nursing and Podiatry, Faculty of Health Sciences, Instituto de Investigación Biomédica de Málaga (IBIMA), Ampliación de Campus de Teatinos, University of Malaga, Arquitecto Francisco Peñalosa 3, 29071 Málaga, Spain
Ricardo Becerro- de-Bengoa-Vallejo: Facultad de Enfermería, Fisioterapia y Podología, Universidad Complutense de Madrid, 28040 Madrid, Spain
Marta Elena Losa-Iglesias: Faculty of Health Sciences, Universidad Rey Juan Carlos, 28933 Alcorcón, Spain
Daniel López-López: Research, Health and Podiatry Group, Department of Health Sciences, Faculty of Nursing and Podiatry, Universidade da Coruña, 15403 Ferrol, Spain
César Calvo-Lobo: Facultad de Enfermería, Fisioterapia y Podología, Universidad Complutense de Madrid, 28040 Madrid, Spain
Patricia Palomo-López: University Center of Plasencia, Universidad de Extremadura, 10600 Plasencia, Spain
Carlos Romero-Morales: Faculty of Sport Sciences, Universidad Europea de Madrid, Villaviciosa de Odón, 28670 Madrid, Spain
Emmanuel Navarro-Flores: Frailty Research Organized Group, Department of Nursing, Faculty of Nursing and Podiatry, Universidad de Valencia, 46010 Valencia, Spain

IJERPH, 2021, vol. 18, issue 5, 1-7

Abstract: Parkinson’s disease is a common neurodegenerative disease and it is known to cause motor disturbances associated with musculoskeletal problems of the locomotor apparatus, and non-motor symptoms, that are believed to have a harmful effect on health, social functioning and mobility. The aim of this study was to evaluate depression in patients with Parkinson’s Disease (PD) compared to subjects who do not have it. The sample consisted of 124 participants (mean age 69.18 ± 9.12). Patients with PD were recruited from a center of excellence for Parkinson’s disease (cases n = 62) and healthy subjects without PD from their relatives and caregivers (control n = 62). The Spanish version of Beck’s Depression Inventory (BDI) scores and categories were collected. A clear statistically significant difference ( p < 0.05) was evident in the BDI scores between both groups. Parkinson’s patients presented worse results on the BDI = 15.48 ± 7.24 points compared to healthy subjects with BDI = 7.03 ± 6.99 points. Regarding BDI categories, there were statistically significant differences ( p < 0.001) for the greater BDI categories in the Parkinson’s group compared with healthy subjects. The depression represents an important potential risk for increased symptoms and negative impact among patients with PD compared with healthy subjects.

Keywords: beck depression inventory; depression; Parkinson disease (search for similar items in EconPapers)
JEL-codes: I I1 I3 Q Q5 (search for similar items in EconPapers)
Date: 2021
References: View complete reference list from CitEc
Citations:

Downloads: (external link)
https://www.mdpi.com/1660-4601/18/5/2369/pdf (application/pdf)
https://www.mdpi.com/1660-4601/18/5/2369/ (text/html)

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:gam:jijerp:v:18:y:2021:i:5:p:2369-:d:508085

Access Statistics for this article

IJERPH is currently edited by Ms. Jenna Liu

More articles in IJERPH from MDPI
Bibliographic data for series maintained by MDPI Indexing Manager ().